Pablo Conesa-Zamora

16PUBLICATIONS
53CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical biotechnology not elsewhere classifiedCancer geneticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 14, 2025
Docetaxel Resistance in Breast Cancer: Current Insights and Future Directions.

Fátima Postigo-Corrales, Asunción Beltrán-Videla, Antonio David Lázaro-Sánchez

|Apr 17, 2025
Expression of Fascin and DNA Topoisomerase 2-Alpha in Breast Carcinoma: Correlation with Histological Subtypes and Other Prognostic Markers.

Alberto Sánchez-Espinosa, José García-Rodríguez, Virginia Alonso-Aguirre

|Feb 26, 2025
Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report.

Antonio David Lazaro Sanchez, Javier David Benitez Fuentes, Ginés Luengo Gil

|Dec 13, 2023
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis.

Yu Muta, Juan F Linares, Anxo Martinez-Ordoñez

|Mar 14, 2022
Potential Utility of Induced Translocation of Engineered Bacteria as a Therapeutic Agent for Mounting a Personalized Neoantigen-Based Tumor Immune Response.

Ginés Luengo-Gil, Pablo Conesa-Zamora

|Dec 10, 2021
Pharmacogenetic role of vitamin D-binding protein and vitamin D receptor polymorphisms in the treatment response of dialysis patients with secondary hyperparathyroidism.

Rosa de Alarcón, Begoña Alburquerque-González, África Fernández-Valera

Pageof 3

Frequent Collaborators

3 joint publications

Ginés Luengo-Gil

2 joint publications

Antonio David Lázaro-Sánchez

2 joint publications

Ana Belén Arroyo Rodríguez

2 joint publications

Silvia Montoro-García